A Systematic Comparison Identifies an ATP-Based Viability Assay as Most Suitable Read-Out for Drug Screening in Glioma Stem-Like Cells

<div>Validation of the crystal violet assay on primary glioma stem-like cell cultures. The crystal violet (CV) assay was applied on four primary glioma stem-like cell cultures. Cells were treated with 50 <i>μ</i>M (white bar) or 100 <i>μ</i>M (black bars) TMZ (a) and 3 Gy (white bars) or 6 Gy (black bars) radiation (b). Read-out was after 5 days. Error bars indicate standard deviation.</div>

Stem Cells International

fig4

Figure 4

Figure 4: A Systematic Comparison Identifies an ATP-Based Viability Assay as Most Suitable Read-Out for Drug Screening in Glioma Stem-Like Cells 